Press Release Details

Quest Diagnostics Names Two New Finance Executives

10/15/1998

TETERBORO, N.J., OCTOBER 15, 1998--Quest Diagnostics Incorporated (NYSE: DGX) today said it appointed Scott Cartier to the position of Corporate Controller and Cathy Doherty to the position of Chief Accounting Officer. Both will report to Bob Hagemann, Vice President and Chief Financial Officer.

Mr. Cartier, 42, who has been with Quest Diagnostics since 1994, has served as Controller for Quest DiagnosticsÂ’ northern New England business unit, based in Cambridge, Massachusetts. Prior to that, he held a number of key posts on the corporate finance staff.

Ms. Doherty, 36, who has been with Quest Diagnostics since 1990, plays a key role in the areas of Business Development and Investor Relations. With this appointment, her duties have been expanded to include responsibility for all external financial reporting.

Ms. Doherty resides in Dumont, New Jersey. Mr. Cartier will be relocating to the metropolitan area.

Quest Diagnostics is one of the nation's leading providers of diagnostic testing, information and services to physicians, hospitals, managed care organizations, employers and government agencies. The wide variety of tests performed on human tissue and fluids help doctors and hospitals diagnose, treat and monitor disease. Its Nichols Institute unit conducts research, specializes in esoteric testing using genetic screening and other advanced technologies, performs clinical studies testing, and manufactures and distributes diagnostic test kits and instruments. Quest Informatics collects and analyzes laboratory, pharmaceutical and other data to help large health care customers identify and monitor patients who are at-risk for certain diseases. Additional company information can be found on the Internet at: www.questdiagnostics.com.